OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Cardiology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
The role of artificial intelligence in early detection and intervention of coronary artery disease	25
Genetics of sudden cardiac death	20
Editorial: from albuminuria to uric acid – emerging risk factors beyond lipids	15
Editorial introductions	15
Assessment and management of neonates with unrepaired congenital heart disease	15
Vascular regenerative cells in cardiometabolic disease	14
Role of medical management of cardiogenic shock in the era of mechanical circulatory support	13
Device therapy for heart failure management	13
Pemafibrate and other triglyceride-lowering therapies to reduce risk of cardiovascular and metabolic disease	13
Advances in device-based therapies for cardiorenal syndrome	12
REVIVED BCIS-2: update and key learnings	12
Team-based strategies to prevent heart failure	11
Editorial introductions	11
Epigenetic remodeling in heart failure with preserved ejection fraction	11
Donation after circulatory determination of death in heart transplant: impact on current and future allocation policy	11
Editorial introductions	11
Clinical considerations and pathophysiological associations among obesity, weight loss, heart failure, and hypertension	11
Imaging of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy	10
Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B for cardiovascular care	10
Radiofrequency lesion formation prediction with contact force versus local impedance	10
Cardiac phenotypes in LMNA mutations	10
Multimodality cardiovascular imaging in hypertension	10
The impact of transcatheter edge-to-edge repair on mitral valve annular geometry	9
Management of hypertension in heart transplant recipients: an ongoing conundrum	8
Sleep apnea and cardiovascular risk	8

Editorial introductions	8
Cardiac selectivity in pulsed field ablation	8
Bicuspid aortic valve associated aortopathy: 2022 guideline update	8
Near infrared spectroscopy in the pediatric cardiac intensive care unit: accurately interpreting the data	8
Wellness and burnout in cardiac surgery: not black and white	8
The mitral valve in hypertrophic cardiomyopathy	7
Management of difficult coronary anatomy during transcatheter aortic valve implantation: what are the key issues?	7
Mapping and ablation of intramural premature ventricular complexes: state-of-the-art review	7
Impact of glucagon-like peptide-1 receptor agonists on hypertension management: a narrative review	7
Weight loss and atrial fibrillation: a review	7
Integration of palliative care across the spectrum of heart failure care and therapies: considerations, contemporary data, and challenges	7
Expanding revascularization trials to women and underserved minorities and shifting to patient-centered outcomes: RECHARGE trials program	7
Is the world ready for the STICH 3.0 trial?	7
Electrographic flow mapping of atrial fibrillation	6
Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?	6
Promoting gender diversity and ergonomic equity in the cardiac surgery operating room	6
New wrinkles in hypertension management 2022	6
Editorial introductions	6
When should the tricuspid valve be repaired during mitral valve repair?	6
Albuminuria and cardiorenal risk	6
Factor XI inhibitors: what should clinicians know	6
Bad behavior in healthcare: an insidious threat to patients, staff, and organizations	6
Update on the molecular landscape of thoracic aortic aneurysmal disease	6
Editorial introductions	5
Robotic mitral valve surgery: evolving history, techniques, and training paths	5
Disparity issues in coronary artery surgery	5
Long noncoding RNAs in cardiovascular disease	5
Peripheral arterial disease and hypertension	5
Symptoms, coronary artery disease and percutaneous coronary intervention: connecting the dots	5
How to deal with nonsevere stenoses in coronary artery bypass grafting – a critical perspective on competitive flow and surgical precision	5
Improving diversity in cardiac surgery clinical trials with ROMA:Women as an exemplar	5
Destination LVAD therapy in the current era of the heart transplant allocation system	5
Mitral valve surgery after failed transcatheter edge-to-edge repair: a review and word of caution	5
Clinical trials of cell therapy for heart failure: recent results warrant continued research	5
Artificial sweeteners and cardiovascular risk	5
Electronic health strategies to improve medication adherence in patients with cardiometabolic disease: current status and future directions	5
A tale of two balloons: technical and procedural difference between cryoballoon systems	5
Recent advances in cardiac imaging: emerging use of three-dimensional visualization for analyzing complex cardiovascular anatomy	5
The management of new-onset atrial fibrillation in critical illness: an update on current therapeutic options	4
Left main revascularization guidelines: navigating the data	4
Management of pregnancy in left ventricular assist device and heart transplant recipients: a concise review	4
Editorial introductions	4
Building resilient heart center teams	4
Double outlet right ventricle – the 50% rule has always been about the conus	4
High lipoprotein(a) is a risk factor for peripheral artery disease, abdominal aortic aneurysms, and major adverse limb events	4
Clinical impact of genetic testing for lipid disorders	4
Patient selection in robotic mitral valve surgery	4
Statin-Associated muscle symptoms and vitamin D supplementation	4
Teaching minimally invasive coronary artery bypass grafting: a structured framework for well tolerated adoption and training	4
Postmyocardial infarction ventricular septal rupture: optimizing surgical timing and repair	4

Influenza vaccination in mitigating vascular events and risk	4
Coronary artery calcium and sudden cardiac death: current evidence and future directions	4
Editorial: the year in lipids and emerging risk factors	4
Pharmacogenetics of cardiovascular drugs	4